Chasteberry Gummy
Natural health product licensed in Canada
- Licence holder
- Purever Nutrition Inc.
- NPN or DIN-HM
- 80133027
- Status
- Active licence
- Licence date
- 30 July 2024
- Revision date
- Not provided
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 50 mg | 10 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 10 mg | Not calculated |
| Zinc Source : Citrate de zinc | 5 mg | Not calculated |
| Calcium | 32.5 mg | Not calculated |
Non-medicinal ingredients
Erythritol, Isomaltooligosaccharides, Citrate de sodium, Xylitol, Huile de tournesol, Jus de carotte noire, Acide citrique, farine de riz, Extrait de feuilles de stévia, Pectine, Saveur, Maltodextrines résistantes, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18 years | 2 Bloc | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms. Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities. Used in Herbal Medicine to help relieve premenstrual symptoms. A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Helps in connective tissue formation. Helps in energy metabolism/(and) tissue formation. Helps maintain healthy skin and connective tissue formation. Helps to maintain/support healthy bones/hair/nail/(and) skin. Helps to maintain/support healthy skin. Maintains/supports healthy bones/hair/nail/(and) skin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80133027
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.